Concord, MA, United States of America

Steven A Haney


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steven A. Haney: Innovator in Apoptosis Modulation

Introduction

Steven A. Haney is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of apoptosis. His work focuses on the development of innovative methods and compounds that can potentially lead to breakthroughs in treating neurological disorders and cancers.

Latest Patents

Haney holds a patent for "Methods of modulating apoptosis using inhibitors of brain-localized protein kinases homologous to homeodomain-interacting protein kinases." This invention provides isolated protein kinase polypeptides related to novel brain-localized protein kinases, termed HIPK4. The patent also includes isolated nucleic acid molecules that encode these polypeptides, as well as inhibitors and methods related to their use. The invention further encompasses genetically engineered expression vectors, host cells, and transgenic animals that incorporate the novel nucleic acid molecules. Additionally, it provides antisense and RNAi molecules, along with inhibitors, activators, and antibodies that can bind to the protein kinase polypeptides. The applications of HIPK4 and its inhibitors are aimed at modulating apoptosis and addressing various neurological disorders and cancers.

Career Highlights

Steven A. Haney is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative research that bridges the gap between basic science and clinical applications. His contributions have been instrumental in advancing the understanding of apoptosis and its implications in health and disease.

Collaborations

Haney has collaborated with notable colleagues, including Wei Liu and Bradley A. Ozenberger. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.

Conclusion

Steven A. Haney's innovative work in the modulation of apoptosis represents a significant advancement in biomedical research. His contributions have the potential to lead to new therapeutic strategies for treating serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…